Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016, 160(2):219-221 | DOI: 10.5507/bp.2016.019

Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication

David Stejskala,b,c, Jan Vaclavikd, Ales Smekald, Gabriela Svobodovaa,b, Radmila Richterovae, Marek Svestaka,b
a AGEL Research and Training Institute, Prostejov, Czech Republic
b Institute of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
c Department of Biomedical Sciences, Faculty of Medicine, Ostrava University, Czech Republic
d Department of Internal Medicine I - Cardiology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
e Agel Laboratories, Novy Jicin, Czech Republic

Objectives: Omentin-1 is an adipokine which could have a protective role against the manifestation of atherosclerosis. Only limited data are available on omentin-1 serum values in patients with premature clinical manifestations of atherosclerosis.

Design and Methods. We tested omentin-1 in human serum by ELISA method in 61 individuals with a premature manifestation of coronary artery disease (CAD), 40 patients with metabolic syndrome and 40 healthy control subjects.

Results: Omentin-1 serum levels were significantly lower in patients with CAD (103.1±62.7 mg/L) compared to metabolic syndrome (668.2±339.6 mg/L) and healthy subjects (623.0±373.5 mg/L) (P < 0.01). In CAD patients, omentin-1 serum levels did not differ between patients sampled in the acute phase of myocardial infarction (n = 28; 110.3±82.4 mg/L) and in the chronic phase several months or years after myocardial infarction (n = 33; 97.0±39.3 mg/L) (P = 0.41). We found a weak positive correlation between omentin-1 and body mass index (r = 0.21, P = 0.014). No significant correlation was found between peak cardiac troponin T and omentin-1 (correlation coefficient r = 0.118, P = 0.406).

Conclusion: Serum omentin-1 seems to be a useful biomarker of coronary artery disease across the whole age spectrum.

Keywords: omentin-1, acute myocardial infarction, coronary artery disease, premature manifestation, adipokines, ELISA

Received: November 12, 2015; Accepted: March 30, 2016; Prepublished online: April 20, 2016; Published: June 24, 2016  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Stejskal, D., Vaclavik, J., Smekal, A., Svobodova, G., Richterova, R., & Svestak, M. (2016). Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication. Biomedical papers, 160(2), 219-221. doi: 10.5507/bp.2016.019
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Schäffler A, Neumeier M, Herfarth H, Fürst A, Schölmerich J, Büchler C: Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochemica et Biophysica acta 2005;1732:96-102. Go to original source...
    2. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, and Gong DW: Identification of omentin as a novel depot-specific adipokine in Human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006;290:E1253-E1261. Go to original source... Go to PubMed...
    3. Kocijancic M, Vujicic B, Racki S, Cubranic Z, Zaputovic L, Dvornik S. Serum omentin-1 levels as a possible risk factor of mortality in patients with diabetes on haemodialysis. Diabetes Res Clin Pract 2015;110(1):44-50. doi: 10.1016/j.diabres.2015.06.008 Go to original source... Go to PubMed...
    4. Onur I, Oz F, Yildiz S, Kuplay H, Yucel C, Sigirci S, Elitok A, Pilten S, Kasali K, Yasar Cizgici A, Erentug V, Dinckal HM. A decreased serum omentin-1 level may be an independent risk factor for peripheral arterial disease. Int Angiol 2014;33:455-6. Go to PubMed...
    5. Yin J, Hou P, Wu Z, Nie Y. Decreased levels of serum omentin-1 in patients with inflammatory bowel disease. Med Sci Monit 2015;21:118-22. doi: 10.12659/MSM.892081 Go to original source... Go to PubMed...
    6. Garcés MF, Ruíz-Linares CE, Vallejo SA, et al. Maternal serum omentin-1 profile is similar in humans and in the rat animal model. Cytokine 2015;75(1):136-41. doi: 10.1016/j.cyto.2015.06.014 Go to original source... Go to PubMed...
    7. Onur I, Oz F, Yildiz S, Oflaz H, Sigirci S, Elitok A, Pilten S, Karaayvaz EB, Cizgici AY, Kaya MG, Onur ST, Sahin I, Dinckal HM. Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women. Angiology 2014;65(10):896-900. Go to original source... Go to PubMed...
    8. Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011;219(2):811-4. Go to original source... Go to PubMed...
    9. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Circulation 2009;120(16):1640-5. Go to original source... Go to PubMed...
    10. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD et al. and ESC Committee for Practice Guidelines. Third universal definition of myocardial infarction. Eur Heart J 2012;33(20):2551-67. Go to original source... Go to PubMed...
    11. Shang FJ, Wang JP, Liu XT, Zheng QS, Xue YS, Wang B, Zhao LY. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 2011;16(8):657-62. Go to original source... Go to PubMed...
    12. Kodoglou NP, Tahmatzidis DK,  Giannakoulas C, Kapelouzou A, Gkontopoulos A, Parissis J, Lampropoulos S, Kottas G. Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY. J Cardiovasc Med (Hagerstown) 2015;16:341-6. Go to original source... Go to PubMed...
    13. Wittenbecher C, di Giuseppe R, Biemann R, Menzel J, Arregui M, Hoffmann J, Aleksandrova K, Boeing H, Isermann B,Schulze MB, Weikert C. Reproducibility of Retinol Binding Protein 4 and Omentin-1 Measurements over a Four Months Period: A Reliability Study in a Cohort of 207 Apparently Healthy Participants. PLoS One 2015;10:e0138480. Go to original source... Go to PubMed...
    14. De Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, and McLenithan JC: Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007; 56:1655-61. Go to original source... Go to PubMed...
    15. Wilms B, Ernst B, Gerig R, Schultes B. Plasma omentin-1 levels are related to exercise performance in obese women and increase upon aerobic endurance training. Exp Clin Endocrinol Diabetes 2015;123(3):187-92. Go to original source... Go to PubMed...

    Return to the content